Health-related quality of life (HRQoL) is important in basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) management. Disease-specific questionnaires exist, but with important shortcomings. Our goal was to develop and validate a questionnaire suitable for use in all BCC and SCC patients. In a four-phase trajectory, a preliminary questionnaire was created and tested population-based (1173 patients). The questionnaire was reduced using exploratory factor analysis and item response theory. Individual item performance was assessed using classical test theory. 721 patients completed the questionnaire. The number of items was reduced to 16, covering five scales. Confirmatory factor analysis showed a good fit. Cronbach's αs (range 0.67 -0.82) were reasonable to high with good internal consistency. The Basal and Squamous cell carcinoma Quality of Life questionnaire has good face, content and construct validity. It is useful in the wide range of BCC and SCC patients and captures HRQoL impact in different timeframes.
INTRODUCTION
The use of patient-reported outcome measures (PROMs) and more specifically healthrelated quality of life (HRQoL) in dermatology patients has dramatically increased over the past decades. It is now an essential outcome for clinical studies and in daily practice, especially in chronic inflammatory skin diseases [1, 2] . In skin cancer, the use of PROMs and HRQoL has only been used over the past two decades and most of the focus has been on melanoma [3] . Since the incidence of basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) is increasing rapidly [4] [5] [6] , the need for PROMs assessment including HRQoL is warranted to evaluate individual and global disease burden. Generic, cancer or even melanoma specific HRQoL instruments are neither content specific nor sensitive enough to detect the impact of the rarely life-threatening BCCs and SCCs that are most often treated by conventional excision. A specific issue for keratinocytic cancers is that patients are likely to develop multiple carcinomas and also actinic keratosis (AK) (so called actinic neoplasia syndrome) and that they can check their skin constantly [7] .
Measurement of HRQoL in BCC patients has occurred in several studies, using generic, cancer related and dermatology specific questionnaires, all reporting little to no impact [7] [8] [9] [10] [11] [12] [13] .
A few disease specific questionnaires have been developed, but these have several important shortcomings. The Skin Cancer Index (SCI) is developed and tested only in a tertiary care Mohs surgery clinic and therefore only suitable for use in a selected population [14, 15] . The Skin Cancer Quality of Life Impact Tool (SCQOLIT) is developed as a tool for nonmetastatic skin cancer patients [16] . A limitation of the SCQOLIT is the addressing of five psychological issues regarding two different aspects in one item. In contrast to the SCI and the SCQOLIT , the Skin Cancer Quality of Life Questionnaire (SCQoL) was developed and validated with modern test theory, namely Rasch analysis [17] . This instrument was however derived from the previously developed Actinic Keratosis Quality of Life questionnaire (AKQoL) and pre-tested in a small sample (18 AK patients, 14 skin cancer patients) with the objective to distinguish the difference between AK and skin cancer patients [18] . From a content validity perspective, we feel that the before mentioned questionnaires do not to capture the psychological issues due to the often required behavioural changes to reduce sun exposure [19] .
The objective of this study is to create and validate a HRQoL questionnaire suitable for BCC and SCC patients addressing relevant issues for patients and healthcare providers using different methodological approaches.
METHODS

Study design
The BCC and SCC specific HRQoL questionnaire was prepared and developed following the European Organisation for Research and Treatment of Cancer (EORTC) QOL group guidelines as much as possible [20] [21] [22] . However, the questionnaire is not an EORTC QOL group product and was not developed internationally. The development was conducted in four phases.
Phase I:
The main goal of phase I was to generate an extensive list of HRQoL issues relevant to BCC and SCC patients. One focus group meeting to discuss and generate HRQoL issues was facilitated by two independent psychologists with no in-depth skin cancer knowledge. The group consisted of 10 BCC and/or SCC patients with different types and numbers of tumours, treatments, gender and age. The audio recording of the focus group was analysed by RWS to extract as much issues as possible without formal transcribing. Extensive literature searches through PubMed (Table S4 ) and semi-structured interviews with 5 healthcare providers (HCP) provided additional issues [23] .
The issues were discussed in an expert panel including dermatologists, psychologists and epidemiologists to identify the relevant disease-specific domains and issues (figure 1).
The remaining issues were presented to HCP (dermatologists, plastic surgeons, ophthalmologist, head-neck ENT surgeon, general practitioners) and patients for feedback and cognitive debriefing. They were also asked to rate the issues for relevance from 1 (not relevant) to 4 (very relevant) on a Likert scale (relevance rating). Issues with relevance mean score ≥ 1.5 were selected for priority rating. HCP and patients were asked to select 15 core issues to be included in the questionnaire (priority rating). Priority ratings of ≥ 30% were scored in het HCP group and ≥ 20% in the patient group. Issues scoring ≥ 3 criteria were included in the final issue list [20] .
Phase II:
The final issue list was rephrased into questions compatible with the EORTC QLQ-C30 in terms of format of response categories [24] . The time frame of the questions was divided into three parts ('since diagnosis', 'time between diagnosis and treatment' and 'during the past week') since the items fitted different timeframes.
Phase III:
The item questionnaire was pretested in 16 patients.
Phase IV:
The questionnaire was field tested in 1,173 patients selected from the Netherlands Cancer Registry, as collected by Comprehensive Cancer Centre Netherlands, location Eindhoven. Patients were selected if they were diagnosed in one of the nine participating hospitals or clinics during the past twelve months before the field testing. The aim of the field testing was to determine scale structure, reliability, validity and to reduce the number of items. The Skindex-17 and the QLQ-C30 were also administered.
Statistical analysis
Descriptive statistics (means and percentages) were used in phase II to calculate relevance and priority ratings of the issue list and in phase IV to describe the patient characteristics. Type of BCC was grouped as multifocal (8091 of the International Classification of Disease for Oncology [ICD-O3] ), infiltrating (8092, nodular (8097), other (8090,8093,8094,8095). Aforementioned analyses were performed in IBM SPSS Statistics for Windows, Version 21.0 (Armonk, New York: IBM Corporation).
After phase IV, the components were determined using principal component analyses (PCA) with varimax rotation. The number of components was determined with a Monte Carlo PCA for parallel analysis [25] . We ran two PCAs, one with complete cases and one with mean substitution, with one missing at most. Items with loadings of >0.40, were selected for Item Response Theory (IRT) [26] . IRT was used to select a minimum number of the best discriminating items covering the whole range of the latent traits.
For IRT analysis, we applied the two parameter latent trait model (2PL-ltm) [27] of the ltm package in R version 3.0.0. The 2PL-ltm program results in an ordering of the items on a given trait or component and supplies a discrimination value for each item. The 2PL-ltm program needs binary items as input. By collapsing the four answer category to binary items, some loss of information is induced. This method is preferred over multicategory models, because these do not provide an ordering of the items.
The original categories were "not at all", "a little", "quite a bit " and "very much". For the majority of items the median was between the first and second category, and for this reason we dichotomized between "not at all" and "a little" or more.
The items were selected on basis of their position on the relevant trait or component and their discriminative value. As we postulated an absolute maximum of five items per subscale, we divided the range between the lowest and highest position by five, and we choose from each of these intervals the item with the highest discriminative value. We checked the unidimensionality of the remaining items with the "unidim" test of the ltm package.
After the item reduction by the 2PL-ltm model, item performance features as used in Classical Test Theory (CTT) were tested. The definitions of the features are presented in Table  S5 [28, 29] . Descriptive statistics were used to test item difficulty (missing responses) and response distribution. Spearman's correlation coefficients were calculated for item-test and item-rest correlation, and also to test item discriminant validity. Internal consistency was tested via Cronbach's α coefficients. Stepwise regression was performed in order to check the percentage of variance explained by the items in a subscale. The multitraitmultimethod correlation matrix was used to assess convergent and discriminant validity.
The resulting factors were also tested with oblique confirmatory factor analyses. We applied two analyses, a complete cases analysis and a maximum likelihood analysis with missing values. We evaluated the fit indices according to the recommendations of Kline, Hu & Bentler and Brown [30] [31] [32] . The correlations between the subscales were reported. The confirmatory factor analyses were performed with STATA version 14.1 (College Station, Texas 77845 USA). All P-values were two sided and considered significant if α <0.05.
RESULTS
Phase I-IV:
The focus group meeting resulted in 63 issues, that were extended to 108 issues after literature searches (Table S4 ) and HCP interviews ( Figure 1 ). After an expert consensus meeting 51 issues were eliminated from the list due to overlap of the issues, questions concerning information about the disease, cancer generic issues or other problems that were considered outside of the domain of HRQoL.
The remaining 57 issues were rated (mean scores, range, relevance and priority rating) by 42 patients (mean age of 70 years, 1-30 years since diagnosis, 27 BCC, 5 SCC and 10 diagnosis unknown to the patient) and 15 HCP (7 dermatologists, 1 plastic surgeon, 1 head neck ENT-surgeon, 1 ophthalmologist, 1 radiation oncologist and 4 general practitioners) and resulted in the removal of the 24 issues with lowest relevance and priority ratings ( Figure 1 ).
The remaining 33 issues were constructed into a provisional 33 item questionnaire (Table  S1) This provisional questionnaire was reviewed by 16 patients for readability, clarity of the items and overlapping of the items and none of the items were excluded or rephrased. 
Principal component analyses
The two PCAs (complete cases and with one missing included) both resulted in six components, with the same items loading. Items 23 and 24 formed a separate component, and at face value these items are nearly identical. Leaving out one of them resulted in five components. Item 24 had a higher factor loading than item 23, for this reason item 23 was removed from the analyses. Only item 5 was not eligible, because it had a component loading lower than 0.40.
The five components were labelled as: Worries (8 items, α=0.87), Appearance (7 items, α=0.84), Behaviour (7 items, α=0.85), Diagnosis & Treatment (5 items, α=0.84) and Other people (4 items, α=0.79) ( Table 2 ). 
Item response analyses
The position on the components and discrimination values resulting from the 2PL-ltm analyses are presented in Table 2 . On basis of these values the item set was reduced from 32 to 16 items. The characteristic curves of the selected items are presented in Figure 2 . The "Worries" and "Behaviour" subscales retained 4 items (αs 0.79-0.82), the "Appearance" and "Diagnosis & Treatment" subscales retained three items (αs = 0.71-0.78) and the "Other people" subscale retained 2 items (α = 0.67). The unidim p-value for the 4 selected items of "Worries" was significant (p=0.03), indicating that this subscale was not sufficiently unidimensional. This lack of unidimensionality was caused by item 21. However, the unidim p-value of all 9 items was 0.38 indicating that all 9 items (including 21) belonged to an unidimensional subscale. We decided to include the item in the final questionnaire because we considered it to be a conceptually important aspect and because of the marking of the scale of the highest position on the latent trait. Item 15 in the "Appearance" prevented the program to converge. Inspection of this item showed that it also loaded (0.37) on the "Diagnosis & Treatment" subscale, and thus violated the unidimensionality assumption. It was decided to delete this item from the analyses. After this the unidim test was insignificant for the subscales appearance, behaviour, diagnosis & treatment and other people, indicating that the unidim assumption has been met for these subscales. (Table S1 ). The item characteristic curves depict the placement of the items on a latent ability and its discriminative value. For example, item 3 (provisional item number) discriminates best between patients with a high behavioural score, and item 1 discriminates best in patients with a low score. Additionally, item 9 discriminates better than item 3.
Probability
The resulting 16 item questionnaire was named Basal and Squamous cell carcinoma Quality of Life (BaSQoL) questionnaire. (Table S2 )
Classical Test Theory
The eight CTT item performance features of the newly constructed questionnaire showed that 7 out of 16 items showed only one suboptimal feature and one showed two suboptimal performance features (Table 3) . From a CTT perspective, the overall performance of the BaSQoL is therefore considered as good. There was no significant correlation with the subscales of the Skindex-17 and the QLQ-C30 suggesting different issues were captured.
Confirmatory Factor Analyses
Both the complete cases and the maximum likelihood with missing vales (MLMV) had acceptable to good misfit scores (RMSEA and SRMR) and good goodness of fit (CFI and TLI) ( Table 4 ). The correlations between the subscales were generally low and there were only small differences between the two analyses. (Table S3 ).
Translation
The original Dutch version of the BaSQoL was translated into English by forward-backward translation [22] . (Table S1 ) • Indicates suboptimal performance in a given item feature. Definition of suboptimal performance in Table S5 .
Item numbers displayed are the final BaSQoL item numbers (Table S2 )
Scoring
The individual items are scored from 0 to 3, in which 0 represents no impact and 3 very high impact. The mean score per subscale is calculated as a scale score. A minimum of 50% of the questions within the subscale has to be answered to calculate the subscale score.
DISCUSSION
The BaSQoL questionnaire has been developed methodologically by following the EORTC QOL group guidelines as much as possible [20] [21] [22] and assesses the relevant dimensions of HRQoL in BCC and SCC patients.
The content of the BaSQoL questionnaire shows some overlap with items from the existing questionnaires for skin cancer, such as cancer recurrence or spreading, concerns about scarring and sun behaviour. But the BaSQoL captures a broader spectrum of the issues relevant in BCC and SCC patients such as treatment and diagnosis related issues and long-term behavioural changes [14, 16, 17] . Since our questionnaire was developed and validated in a large Dutch patient sample by using a population based approach, we consider it to be representative for use in the wide range of BCC and SCC patients.
Since patients were extensively involved in the whole process of the development, the questions are representative and in the terminology as used by the patients.
By combining the use of modern IRT and CTT analyses we aimed to create a questionnaire with optimal psychometric properties. Therefore the BaSQoL has good face, content and construct validity. The use of the different time frames in our questionnaire is also a unique feature. Patients noted a difference in behaviour before and after the initial diagnosis. Therefore the impact of this behavioural change is measured in the first part of the BaSQoL. The second part of the BaSQoL concerns the period of diagnosis and treatment. This, usually short, timeframe has a high impact on patients HRQoL. This subscale is suitable for assessing the patient's experience of this specific period in order to manage anxiety in the process in case of new tumours and, in general, to optimize patient care. The final part of the questionnaire addresses the impact of the skin cancer during the past week. Since BCC and SCC are being considered as more chronic diseases, addressing the relevant issues at the right moment is important.
The preliminary validation of the BaSQoL has also been established by this study. Cronbach's αs of the reduced subscales remained reasonable, taking into account that a reduction in the number of items generally leads to lower α [33, 34] . The subscales are psychometrically robust, displaying excellent item performance and a good fit in the confirmatory factor analysis. As the BaSQoL measures different aspects of HRQoL, it showed no significant correlation with the subscales of the Skindex-17 and the QLQ-C30 confirming divergent validity. Unfortunately, none of the previously developed BCC or SCC specific questionnaires were included in this study because there are no validated BCC or SCC specific questionnaires available in Dutch and we intended to minimize respondent burden and increase the response rate. A validation study of the English version of the BaSQoL is underway. Construct validity by comparing to the validated SCI, test-retest stability and responsiveness to change will be addressed in this study. Other important features to increase interpretability such as categorization of scores and minimally clinical important difference remain to be determined.
Item 21 (BaSQoL nr 11) 'Were you uncertain about the future?', that violated the unidim assumption of the worries subscale, also had a suboptimal response distribution ( Table  3 ). The confirmatory factor analysis however, showed a good fit. This item reflects a more generic aspect than the other items in the subscale and it had far the highest position on the latent trait for this reason and because of the conceptual general intent of the item we decided to maintain it within the questionnaire.
In summary, the BaSQoL has good face, content and construct validity. The BaSQoL is representative for use in the wide range of BCC and SCC patients and captures HRQoL impact in different time periods. Therefore we consider the BaSQoL as a useful tool to capture HRQoL impact in future studies. 
Item difficulty
Proportion of missing scores among the 721 respondents. Item difficulty was considered high if 10% or more of scores were missing.
Response distribution
The proportion of patients who responded to each item with the same response was determined. An item was described as having a poor distribution if > 70% of patients had chosen the same response.
3
Item-test correlation
The Spearman's correlation coefficients (r) of each item with its subscale were calculated. If the r of an item differed > 0,1 with the r of the other items in the subscale a , it was considered suboptimal.
4
Item-rest correlation The Spearman's correlation coefficients (r) of each item with the sum of the other items in that subscale a were calculated. Suboptimal item-rest correlation was defined as r < 0,20 5
Item discriminant validity
We compared the item-rest correlation coefficients with the correlation coefficients of an item with the other subscales a . If the former equalled or was smaller than the latter, an item was defined as having poor discriminant validity.
6
Item complexity
We investigated the factor loadings in a factor analysis for each item. Suboptimal complexity was said to exist if the highest loading of an item was < 0,40 or if the difference between the loadings on different factors was < 0,10.
7
Internal consistency For each subscale, the Cronbach's α was calculated. If α < 0,70, the internal consistency was considered suboptimal for each subscale's item.
8
Stepwise regression For each subscale, a forward stepwise regression analysis was performed.
If an item entered the model after 90% or more of the variance of that subscale was explained it was considered suboptimal.
a Subscales derived from the principal component analysis were used.
